Elham Barazeghi
Uppsala, C 75185, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma.
Journal: Endocrine pathology
Published: March 28, 2026
Metformin inhibits small intestinal neuroendocrine tumor growth in vivo.
Journal: BMC cancer
Published: September 24, 2025
Loss of MBD2 is associated with tumor growth in small intestinal neuroendocrine tumors.
Journal: Endocrine connections
Published: March 24, 2025
Searching for peripheral proteomic markers of primary aldosteronism.
Journal: Endocrine
Published: January 07, 2025
Serum microRNAs as peripheral markers of primary aldosteronism.
Journal: Frontiers in endocrinology
Published: October 14, 2024
EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine.
Journal: Scientific reports
Published: February 25, 2021
PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors.
Journal: Endocrine connections
Published: June 26, 2019
5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma.
Journal: Clinical epigenetics
Published: October 12, 2015
The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Journal: Endocrine-related cancer
Published: December 03, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026